[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Darbepoetin Alfa Market Insights, Forecast to 2026

June 2020 | 114 pages | ID: GAE027D34C41EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Darbepoetin Alfa 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Darbepoetin Alfa 3900 industry.
Based on our recent survey, we have several different scenarios about the Darbepoetin Alfa 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5229.2 million in 2019. The market size of Darbepoetin Alfa 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Darbepoetin Alfa market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Darbepoetin Alfa market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Darbepoetin Alfa market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Darbepoetin Alfa market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Darbepoetin Alfa market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Darbepoetin Alfa market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Darbepoetin Alfa market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Darbepoetin Alfa market.
The following manufacturers are covered in this report:
  • Amgen
  • Johnson & Johnson
  • Kyowa Hakko Kirin
  • Novartis
  • 3SBio
  • ...
Darbepoetin Alfa Breakdown Data by Type
  • Epogen
  • Procrit
  • Aranesp
  • Others
Darbepoetin Alfa Breakdown Data by Application
  • Patients with Chronic Kidney Disease
  • Patients with Cancer
  • Others
1 STUDY COVERAGE

1.1 Darbepoetin Alfa Product Introduction
1.2 Market Segments
1.3 Key Darbepoetin Alfa Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Darbepoetin Alfa Market Size Growth Rate by Type
  1.4.2 Epogen
  1.4.3 Procrit
  1.4.4 Aranesp
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Darbepoetin Alfa Market Size Growth Rate by Application
  1.5.2 Patients with Chronic Kidney Disease
  1.5.3 Patients with Cancer
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Darbepoetin Alfa Industry Impact
  1.6.1 How the Covid-19 is Affecting the Darbepoetin Alfa Industry
    1.6.1.1 Darbepoetin Alfa Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Darbepoetin Alfa Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Darbepoetin Alfa Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Darbepoetin Alfa Market Size Estimates and Forecasts
  2.1.1 Global Darbepoetin Alfa Revenue 2015-2026
  2.1.2 Global Darbepoetin Alfa Sales 2015-2026
2.2 Darbepoetin Alfa Market Size by Region: 2020 Versus 2026
  2.2.1 Global Darbepoetin Alfa Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Darbepoetin Alfa Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL DARBEPOETIN ALFA COMPETITOR LANDSCAPE BY PLAYERS

3.1 Darbepoetin Alfa Sales by Manufacturers
  3.1.1 Darbepoetin Alfa Sales by Manufacturers (2015-2020)
  3.1.2 Darbepoetin Alfa Sales Market Share by Manufacturers (2015-2020)
3.2 Darbepoetin Alfa Revenue by Manufacturers
  3.2.1 Darbepoetin Alfa Revenue by Manufacturers (2015-2020)
  3.2.2 Darbepoetin Alfa Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Darbepoetin Alfa Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Darbepoetin Alfa Revenue in 2019
  3.2.5 Global Darbepoetin Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Darbepoetin Alfa Price by Manufacturers
3.4 Darbepoetin Alfa Manufacturing Base Distribution, Product Types
  3.4.1 Darbepoetin Alfa Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Darbepoetin Alfa Product Type
  3.4.3 Date of International Manufacturers Enter into Darbepoetin Alfa Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Darbepoetin Alfa Market Size by Type (2015-2020)
  4.1.1 Global Darbepoetin Alfa Sales by Type (2015-2020)
  4.1.2 Global Darbepoetin Alfa Revenue by Type (2015-2020)
  4.1.3 Darbepoetin Alfa Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Darbepoetin Alfa Market Size Forecast by Type (2021-2026)
  4.2.1 Global Darbepoetin Alfa Sales Forecast by Type (2021-2026)
  4.2.2 Global Darbepoetin Alfa Revenue Forecast by Type (2021-2026)
  4.2.3 Darbepoetin Alfa Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Darbepoetin Alfa Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Darbepoetin Alfa Market Size by Application (2015-2020)
  5.1.1 Global Darbepoetin Alfa Sales by Application (2015-2020)
  5.1.2 Global Darbepoetin Alfa Revenue by Application (2015-2020)
  5.1.3 Darbepoetin Alfa Price by Application (2015-2020)
5.2 Darbepoetin Alfa Market Size Forecast by Application (2021-2026)
  5.2.1 Global Darbepoetin Alfa Sales Forecast by Application (2021-2026)
  5.2.2 Global Darbepoetin Alfa Revenue Forecast by Application (2021-2026)
  5.2.3 Global Darbepoetin Alfa Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Darbepoetin Alfa by Country
  6.1.1 North America Darbepoetin Alfa Sales by Country
  6.1.2 North America Darbepoetin Alfa Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Darbepoetin Alfa Market Facts & Figures by Type
6.3 North America Darbepoetin Alfa Market Facts & Figures by Application

7 EUROPE

7.1 Europe Darbepoetin Alfa by Country
  7.1.1 Europe Darbepoetin Alfa Sales by Country
  7.1.2 Europe Darbepoetin Alfa Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Darbepoetin Alfa Market Facts & Figures by Type
7.3 Europe Darbepoetin Alfa Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Darbepoetin Alfa by Region
  8.1.1 Asia Pacific Darbepoetin Alfa Sales by Region
  8.1.2 Asia Pacific Darbepoetin Alfa Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Darbepoetin Alfa Market Facts & Figures by Type
8.3 Asia Pacific Darbepoetin Alfa Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Darbepoetin Alfa by Country
  9.1.1 Latin America Darbepoetin Alfa Sales by Country
  9.1.2 Latin America Darbepoetin Alfa Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Darbepoetin Alfa Market Facts & Figures by Type
9.3 Central & South America Darbepoetin Alfa Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Darbepoetin Alfa by Country
  10.1.1 Middle East and Africa Darbepoetin Alfa Sales by Country
  10.1.2 Middle East and Africa Darbepoetin Alfa Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 UAE
10.2 Middle East and Africa Darbepoetin Alfa Market Facts & Figures by Type
10.3 Middle East and Africa Darbepoetin Alfa Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Amgen
  11.1.1 Amgen Corporation Information
  11.1.2 Amgen Description, Business Overview and Total Revenue
  11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Amgen Darbepoetin Alfa Products Offered
  11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Corporation Information
  11.2.2 Johnson & Johnson Description, Business Overview and Total Revenue
  11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Johnson & Johnson Darbepoetin Alfa Products Offered
  11.2.5 Johnson & Johnson Recent Development
11.3 Kyowa Hakko Kirin
  11.3.1 Kyowa Hakko Kirin Corporation Information
  11.3.2 Kyowa Hakko Kirin Description, Business Overview and Total Revenue
  11.3.3 Kyowa Hakko Kirin Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Kyowa Hakko Kirin Darbepoetin Alfa Products Offered
  11.3.5 Kyowa Hakko Kirin Recent Development
11.4 Novartis
  11.4.1 Novartis Corporation Information
  11.4.2 Novartis Description, Business Overview and Total Revenue
  11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Novartis Darbepoetin Alfa Products Offered
  11.4.5 Novartis Recent Development
11.5 3SBio
  11.5.1 3SBio Corporation Information
  11.5.2 3SBio Description, Business Overview and Total Revenue
  11.5.3 3SBio Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 3SBio Darbepoetin Alfa Products Offered
  11.5.5 3SBio Recent Development
11.1 Amgen
  11.1.1 Amgen Corporation Information
  11.1.2 Amgen Description, Business Overview and Total Revenue
  11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Amgen Darbepoetin Alfa Products Offered
  11.1.5 Amgen Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Darbepoetin Alfa Market Estimates and Projections by Region
  12.1.1 Global Darbepoetin Alfa Sales Forecast by Regions 2021-2026
  12.1.2 Global Darbepoetin Alfa Revenue Forecast by Regions 2021-2026
12.2 North America Darbepoetin Alfa Market Size Forecast (2021-2026)
  12.2.1 North America: Darbepoetin Alfa Sales Forecast (2021-2026)
  12.2.2 North America: Darbepoetin Alfa Revenue Forecast (2021-2026)
  12.2.3 North America: Darbepoetin Alfa Market Size Forecast by Country (2021-2026)
12.3 Europe Darbepoetin Alfa Market Size Forecast (2021-2026)
  12.3.1 Europe: Darbepoetin Alfa Sales Forecast (2021-2026)
  12.3.2 Europe: Darbepoetin Alfa Revenue Forecast (2021-2026)
  12.3.3 Europe: Darbepoetin Alfa Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Darbepoetin Alfa Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Darbepoetin Alfa Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Darbepoetin Alfa Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Darbepoetin Alfa Market Size Forecast by Region (2021-2026)
12.5 Latin America Darbepoetin Alfa Market Size Forecast (2021-2026)
  12.5.1 Latin America: Darbepoetin Alfa Sales Forecast (2021-2026)
  12.5.2 Latin America: Darbepoetin Alfa Revenue Forecast (2021-2026)
  12.5.3 Latin America: Darbepoetin Alfa Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Darbepoetin Alfa Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Darbepoetin Alfa Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Darbepoetin Alfa Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Darbepoetin Alfa Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Darbepoetin Alfa Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Darbepoetin Alfa Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details

LIST OF TABLES

Table 1. Darbepoetin Alfa Market Segments
Table 2. Ranking of Global Top Darbepoetin Alfa Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Darbepoetin Alfa Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Epogen
Table 5. Major Manufacturers of Procrit
Table 6. Major Manufacturers of Aranesp
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Darbepoetin Alfa Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Darbepoetin Alfa Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Darbepoetin Alfa Players to Combat Covid-19 Impact
Table 13. Global Darbepoetin Alfa Market Size Growth Rate by Application 2020-2026 (M Units)
Table 14. Global Darbepoetin Alfa Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 15. Global Darbepoetin Alfa Sales by Regions 2015-2020 (M Units)
Table 16. Global Darbepoetin Alfa Sales Market Share by Regions (2015-2020)
Table 17. Global Darbepoetin Alfa Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Darbepoetin Alfa Sales by Manufacturers (2015-2020) (M Units)
Table 19. Global Darbepoetin Alfa Sales Share by Manufacturers (2015-2020)
Table 20. Global Darbepoetin Alfa Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Darbepoetin Alfa by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Darbepoetin Alfa as of 2019)
Table 22. Darbepoetin Alfa Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Darbepoetin Alfa Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Darbepoetin Alfa Price (2015-2020) (USD/Unit)
Table 25. Darbepoetin Alfa Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Darbepoetin Alfa Product Type
Table 27. Date of International Manufacturers Enter into Darbepoetin Alfa Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 30. Global Darbepoetin Alfa Sales Share by Type (2015-2020)
Table 31. Global Darbepoetin Alfa Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Darbepoetin Alfa Revenue Share by Type (2015-2020)
Table 33. Darbepoetin Alfa Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 35. Global Darbepoetin Alfa Sales Share by Application (2015-2020)
Table 36. North America Darbepoetin Alfa Sales by Country (2015-2020) (M Units)
Table 37. North America Darbepoetin Alfa Sales Market Share by Country (2015-2020)
Table 38. North America Darbepoetin Alfa Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Darbepoetin Alfa Revenue Market Share by Country (2015-2020)
Table 40. North America Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 41. North America Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 42. North America Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 43. North America Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 44. Europe Darbepoetin Alfa Sales by Country (2015-2020) (M Units)
Table 45. Europe Darbepoetin Alfa Sales Market Share by Country (2015-2020)
Table 46. Europe Darbepoetin Alfa Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Darbepoetin Alfa Revenue Market Share by Country (2015-2020)
Table 48. Europe Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 49. Europe Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 50. Europe Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 51. Europe Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Darbepoetin Alfa Sales by Region (2015-2020) (M Units)
Table 53. Asia Pacific Darbepoetin Alfa Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Darbepoetin Alfa Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Darbepoetin Alfa Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 57. Asia Pacific Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 59. Asia Pacific Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 60. Latin America Darbepoetin Alfa Sales by Country (2015-2020) (M Units)
Table 61. Latin America Darbepoetin Alfa Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Darbepoetin Alfa Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Darbepoetin Alfa Revenue Market Share by Country (2015-2020)
Table 64. Latin America Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 65. Latin America Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 66. Latin America Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 67. Latin America Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Darbepoetin Alfa Sales by Country (2015-2020) (M Units)
Table 69. Middle East and Africa Darbepoetin Alfa Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Darbepoetin Alfa Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Darbepoetin Alfa Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Darbepoetin Alfa Sales by Type (2015-2020) (M Units)
Table 73. Middle East and Africa Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Darbepoetin Alfa Sales by Application (2015-2020) (M Units)
Table 75. Middle East and Africa Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 76. Amgen Corporation Information
Table 77. Amgen Description and Major Businesses
Table 78. Amgen Darbepoetin Alfa Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Amgen Product
Table 80. Amgen Recent Development
Table 81. Johnson & Johnson Corporation Information
Table 82. Johnson & Johnson Description and Major Businesses
Table 83. Johnson & Johnson Darbepoetin Alfa Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Johnson & Johnson Product
Table 85. Johnson & Johnson Recent Development
Table 86. Kyowa Hakko Kirin Corporation Information
Table 87. Kyowa Hakko Kirin Description and Major Businesses
Table 88. Kyowa Hakko Kirin Darbepoetin Alfa Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Kyowa Hakko Kirin Product
Table 90. Kyowa Hakko Kirin Recent Development
Table 91. Novartis Corporation Information
Table 92. Novartis Description and Major Businesses
Table 93. Novartis Darbepoetin Alfa Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Novartis Product
Table 95. Novartis Recent Development
Table 96. 3SBio Corporation Information
Table 97. 3SBio Description and Major Businesses
Table 98. 3SBio Darbepoetin Alfa Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. 3SBio Product
Table 100. 3SBio Recent Development
Table 101. Global Darbepoetin Alfa Sales Forecast by Regions (2021-2026) (M Units)
Table 102. Global Darbepoetin Alfa Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Darbepoetin Alfa Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Darbepoetin Alfa Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Darbepoetin Alfa Sales Forecast by Country (2021-2026) (M Units)
Table 106. North America: Darbepoetin Alfa Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Darbepoetin Alfa Sales Forecast by Country (2021-2026) (M Units)
Table 108. Europe: Darbepoetin Alfa Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Darbepoetin Alfa Sales Forecast by Region (2021-2026) (M Units)
Table 110. Asia Pacific: Darbepoetin Alfa Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Darbepoetin Alfa Sales Forecast by Country (2021-2026) (M Units)
Table 112. Latin America: Darbepoetin Alfa Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Darbepoetin Alfa Sales Forecast by Country (2021-2026) (M Units)
Table 114. Middle East and Africa: Darbepoetin Alfa Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Darbepoetin Alfa Players
Table 119. Darbepoetin Alfa Customers List
Table 120. Darbepoetin Alfa Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Darbepoetin Alfa Product Picture
Figure 2. Global Darbepoetin Alfa Sales Market Share by Type in 2020 & 2026
Figure 3. Epogen Product Picture
Figure 4. Procrit Product Picture
Figure 5. Aranesp Product Picture
Figure 6. Others Product Picture
Figure 7. Global Darbepoetin Alfa Sales Market Share by Application in 2020 & 2026
Figure 8. Patients with Chronic Kidney Disease
Figure 9. Patients with Cancer
Figure 10. Others
Figure 11. Darbepoetin Alfa Report Years Considered
Figure 12. Global Darbepoetin Alfa Market Size 2015-2026 (US$ Million)
Figure 13. Global Darbepoetin Alfa Sales 2015-2026 (M Units)
Figure 14. Global Darbepoetin Alfa Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Darbepoetin Alfa Sales Market Share by Region (2015-2020)
Figure 16. Global Darbepoetin Alfa Sales Market Share by Region in 2019
Figure 17. Global Darbepoetin Alfa Revenue Market Share by Region (2015-2020)
Figure 18. Global Darbepoetin Alfa Revenue Market Share by Region in 2019
Figure 19. Global Darbepoetin Alfa Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Darbepoetin Alfa Revenue in 2019
Figure 21. Darbepoetin Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Figure 23. Global Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 24. Global Darbepoetin Alfa Revenue Market Share by Type (2015-2020)
Figure 25. Global Darbepoetin Alfa Revenue Market Share by Type in 2019
Figure 26. Global Darbepoetin Alfa Market Share by Price Range (2015-2020)
Figure 27. Global Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Figure 28. Global Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 29. Global Darbepoetin Alfa Revenue Market Share by Application (2015-2020)
Figure 30. Global Darbepoetin Alfa Revenue Market Share by Application in 2019
Figure 31. North America Darbepoetin Alfa Sales Growth Rate 2015-2020 (M Units)
Figure 32. North America Darbepoetin Alfa Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Darbepoetin Alfa Sales Market Share by Country in 2019
Figure 34. North America Darbepoetin Alfa Revenue Market Share by Country in 2019
Figure 35. U.S. Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 36. U.S. Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 38. Canada Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Darbepoetin Alfa Market Share by Type in 2019
Figure 40. North America Darbepoetin Alfa Market Share by Application in 2019
Figure 41. Europe Darbepoetin Alfa Sales Growth Rate 2015-2020 (M Units)
Figure 42. Europe Darbepoetin Alfa Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Darbepoetin Alfa Sales Market Share by Country in 2019
Figure 44. Europe Darbepoetin Alfa Revenue Market Share by Country in 2019
Figure 45. Germany Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 46. Germany Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 48. France Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 50. U.K. Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 52. Italy Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 54. Russia Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Darbepoetin Alfa Market Share by Type in 2019
Figure 56. Europe Darbepoetin Alfa Market Share by Application in 2019
Figure 57. Asia Pacific Darbepoetin Alfa Sales Growth Rate 2015-2020 (M Units)
Figure 58. Asia Pacific Darbepoetin Alfa Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Darbepoetin Alfa Sales Market Share by Region in 2019
Figure 60. Asia Pacific Darbepoetin Alfa Revenue Market Share by Region in 2019
Figure 61. China Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 62. China Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 64. Japan Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 66. South Korea Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 68. India Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 70. Australia Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 72. Taiwan Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 74. Indonesia Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 76. Thailand Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 78. Malaysia Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 80. Philippines Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 82. Vietnam Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Darbepoetin Alfa Market Share by Type in 2019
Figure 84. Asia Pacific Darbepoetin Alfa Market Share by Application in 2019
Figure 85. Latin America Darbepoetin Alfa Sales Growth Rate 2015-2020 (M Units)
Figure 86. Latin America Darbepoetin Alfa Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Darbepoetin Alfa Sales Market Share by Country in 2019
Figure 88. Latin America Darbepoetin Alfa Revenue Market Share by Country in 2019
Figure 89. Mexico Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 90. Mexico Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 92. Brazil Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 94. Argentina Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Darbepoetin Alfa Market Share by Type in 2019
Figure 96. Latin America Darbepoetin Alfa Market Share by Application in 2019
Figure 97. Middle East and Africa Darbepoetin Alfa Sales Growth Rate 2015-2020 (M Units)
Figure 98. Middle East and Africa Darbepoetin Alfa Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Darbepoetin Alfa Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Darbepoetin Alfa Revenue Market Share by Country in 2019
Figure 101. Turkey Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 102. Turkey Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 104. Saudi Arabia Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Darbepoetin Alfa Sales Growth Rate (2015-2020) (M Units)
Figure 106. UAE Darbepoetin Alfa Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Darbepoetin Alfa Market Share by Type in 2019
Figure 108. Middle East and Africa Darbepoetin Alfa Market Share by Application in 2019
Figure 109. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. 3SBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Darbepoetin Alfa Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 115. North America Darbepoetin Alfa Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Darbepoetin Alfa Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 117. Europe Darbepoetin Alfa Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Darbepoetin Alfa Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 119. Asia Pacific Darbepoetin Alfa Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Darbepoetin Alfa Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 121. Latin America Darbepoetin Alfa Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Darbepoetin Alfa Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 123. Middle East and Africa Darbepoetin Alfa Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed


More Publications